Scancell Holdings Income Statement

Financials in millions GBP. Fiscal year is May - April.

Millions GBP. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	-	4.71	-	5.27	-
Revenue Growth	-	-	-	-	-
Cost of Revenue	-	0.24	-	0.53	-
Gross Profit	-	4.47	-	4.75	-
Selling, General & Admin	5.39	4.79	5.4	5.02	4.79
Research & Development	12.03	14.69	12.87	11.65	9.48
Operating Expenses	17.42	19.47	18.27	16.67	14.26
Operating Income	-17.42	-15	-18.27	-11.92	-14.26
Interest Expense	-1.96	-1.72	-1.09	-1.22	-1.78
Interest & Investment Income	0.3	0.34	0.36	0.28	0
Other Non Operating Income (Expenses)	-1.12	-0.74	9.88	-1.45	16.04
EBT Excluding Unusual Items	-20.21	-17.12	-9.12	-14.3	0.01
Other Unusual Items	-0.02	1.82	-	-	-6.28
Pretax Income	-20.23	-15.3	-9.12	-14.3	-6.27
Income Tax Expense	-2.33	-3.03	-3.26	-2.37	-1.7
Net Income	-17.9	-12.27	-5.86	-11.94	-4.57
Net Income to Common	-17.9	-12.27	-5.86	-11.94	-4.57
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	1,038	970	862	816	815
Shares Outstanding (Diluted)	1,038	970	1,030	816	815
Shares Change	6.93%	-5.78%	26.19%	0.10%	20.13%
EPS (Basic)	-0.02	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.02	-0.01	-0.01	-0.01	-0.01
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Free Cash Flow	-10.78	-6.41	-15.84	-8.34	-11.46
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01
Gross Margin	-	94.95%	-	90.04%	-
Operating Margin	-	-318.43%	-	-226.14%	-
Profit Margin	-	-260.50%	-	-226.45%	-
Free Cash Flow Margin	-	-136.13%	-	-158.28%	-
EBITDA	-17.16	-14.51	-17.71	-11.38	-13.88
EBITDA Margin	-	-	-	-215.97%	-
D&A For EBITDA	0.26	0.49	0.56	0.54	0.38
EBIT	-17.42	-15	-18.27	-11.92	-14.26
EBIT Margin	-	-	-	-226.14%	-